Aclidinium bromide / formoterol fumarate dihydrate (Brimica® Genuair®)

Assessment Status Rapid Review Complete
Drug Aclidinium bromide/formoterol fumarate dihydrate
Brand Brimica®/Genuair®
Indication For treatment to relieve symptoms in adult patients with COPD. (Maintenance bronchodilator)
Assessment Process
Rapid review outcome Full Pharmacoeconomic Evaluation Recommended at submitted price.

The company has not submitted a HTA dossier to the NCPE therefore the cost effectiveness of the technology could not be proven.